Paris - Delayed Quote EUR

Eurofins Scientific SE (ERF.PA)

56.84 -4.76 (-7.73%)
At close: April 24 at 5:35 PM GMT+2
Loading Chart for ERF.PA
DELL
  • Previous Close 61.60
  • Open 60.28
  • Bid --
  • Ask --
  • Day's Range 56.64 - 60.30
  • 52 Week Range 44.83 - 65.24
  • Volume 660,784
  • Avg. Volume 339,103
  • Market Cap (intraday) 10.969B
  • Beta (5Y Monthly) 0.60
  • PE Ratio (TTM) 36.20
  • EPS (TTM) 1.57
  • Earnings Date Jul 24, 2024
  • Forward Dividend & Yield 1.00 (1.62%)
  • Ex-Dividend Date Jul 4, 2023
  • 1y Target Est 59.60

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

www.eurofins.com

61,798

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ERF.PA

Performance Overview: ERF.PA

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ERF.PA
3.63%
CAC 40
7.27%

1-Year Return

ERF.PA
5.41%
CAC 40
6.80%

3-Year Return

ERF.PA
31.62%
CAC 40
29.31%

5-Year Return

ERF.PA
54.84%
CAC 40
44.71%

Compare To: ERF.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ERF.PA

Valuation Measures

Annual
As of 4/23/2024
  • Market Cap

    11.89B

  • Enterprise Value

    14.59B

  • Trailing P/E

    39.24

  • Forward P/E

    21.64

  • PEG Ratio (5yr expected)

    1.36

  • Price/Sales (ttm)

    1.87

  • Price/Book (mrq)

    2.34

  • Enterprise Value/Revenue

    2.24

  • Enterprise Value/EBITDA

    11.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.76%

  • Return on Assets (ttm)

    4.27%

  • Return on Equity (ttm)

    6.16%

  • Revenue (ttm)

    6.51B

  • Net Income Avi to Common (ttm)

    256.5M

  • Diluted EPS (ttm)

    1.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.23B

  • Total Debt/Equity (mrq)

    76.43%

  • Levered Free Cash Flow (ttm)

    511.9M

Research Analysis: ERF.PA

Analyst Price Targets

48.00 Low
59.60 Average
56.84 Current
84.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: ERF.PA

People Also Watch